{
    "Orphapacket": {
        "ORPHApacketId": "401920",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "401920",
        "Label": "Fibrolamellar hepatocellular carcinoma",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_401920",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "FHCC"
            },
            {
                "Synonym": "Fibrolamellar hepatocarcinoma"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare variant of hepatocellular carcinoma (HCC) presenting in adolescents or young adults with no underlying liver disease. Clinical presentation is non specific with abdominal mass abdominal discomfort or pain fatigue and weight loss. Patients can also be asymptomatic. HCC markers (alpha fetoprotein) are normal. Fibrolamellar HCC presents as a unique well-delimited mass at imagery and a biopsy confirms the diagnosis showing well-differentiated tumor cells surrounded by thick collagen bands."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "DNAJB1",
                    "Name": "DnaJ heat shock protein family (Hsp40) member B1",
                    "ExternalReferences": [
                        {
                            "Source": "HGNC",
                            "Reference": "5270"
                        },
                        {
                            "Source": "OMIM",
                            "Reference": "604572"
                        },
                        {
                            "Source": "ClinVar",
                            "Reference": "DNAJB1"
                        }
                    ],
                    "DisorderGeneAssociationType": "Part of a fusion gene in"
                }
            },
            {
                "Gene": {
                    "Symbol": "PRKACA",
                    "Name": "protein kinase cAMP-activated catalytic subunit alpha",
                    "ExternalReferences": [
                        {
                            "Source": "HGNC",
                            "Reference": "9380"
                        },
                        {
                            "Source": "OMIM",
                            "Reference": "601639"
                        },
                        {
                            "Source": "ClinVar",
                            "Reference": "PRKACA"
                        }
                    ],
                    "DisorderGeneAssociationType": "Part of a fusion gene in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "424936",
                        "Label": "Carcinoma of liver and intrahepatic biliary tract"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "602687",
                        "Label": "Pediatric hepatic and biliary tract cancer"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "SEER Surveillance Epidemiology and end results [REG]_14999699[PMID]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "United States"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Austria"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Belgium"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Bulgaria"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Czech Republic"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Estonia"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Finland"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "France"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Germany"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Iceland"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Ireland"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Italy"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Latvia"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Norway"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Poland"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Portugal"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Slovakia"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Spain"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Switzerland"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Netherlands"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "United Kingdom"
                }
            },
            {
                "Prevalence": {
                    "Source": "RARECARE surveillance of rare cancers in Europe[REG]",
                    "PrevalenceType": "Annual incidence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Europe"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adolescent"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Adult"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Not applicable"
                }
            ]
        }
    }
}